Sulfonylureas

PheWeb

SULFONYLUREAS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC A10BB

12150

Check pre-conditions, main-only, mode, ICD version None

10874

Check minimum number of events

Min. number of events 3

10874

Include endpoints None

10874

SULFONYLUREAS

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Sulfonylureas based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	10518	3865	6653
Unadjusted prevalence (%)	3.41	2.23	4.93
Mean age at first event (years)	59.99	60.03	59.97

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.18 [1.92, 2.48]	2.3e-32	3791
15 years	0.01	1.70 [1.53, 1.89]	3.8e-23	2090
5 years	0.00	2.02 [1.83, 2.23]	1.5e-42	766
1 year	0.00	1.82 [1.50, 2.21]	1.8e-9	137

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: SULFONYLUREAS – Sulfonylureas
GWS hits:

Survival analyses between endpoints

↥

Plot

before Sulfonylureas
after Sulfonylureas

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Sulfonylureas

↥